AbbVie Inc (ABBV)
171.73
+3.97
(+2.37%)
USD |
NYSE |
Nov 21, 16:00
172.68
+0.95
(+0.55%)
Pre-Market: 04:22
AbbVie Shareholders Equity (Quarterly): 6.032B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 6.032B |
June 30, 2024 | 6.778B |
March 31, 2024 | 8.007B |
December 31, 2023 | 10.36B |
September 30, 2023 | 12.09B |
June 30, 2023 | 12.87B |
March 31, 2023 | 13.27B |
December 31, 2022 | 17.25B |
September 30, 2022 | 15.99B |
June 30, 2022 | 14.65B |
March 31, 2022 | 16.28B |
December 31, 2021 | 15.41B |
September 30, 2021 | 13.55B |
June 30, 2021 | 12.57B |
March 31, 2021 | 13.71B |
December 31, 2020 | 13.08B |
September 30, 2020 | 15.27B |
June 30, 2020 | 14.71B |
March 31, 2020 | -7.415B |
December 31, 2019 | -8.172B |
September 30, 2019 | -8.226B |
June 30, 2019 | -8.566B |
March 31, 2019 | -7.826B |
December 31, 2018 | -8.446B |
September 30, 2018 | -2.921B |
Date | Value |
---|---|
June 30, 2018 | -3.375B |
March 31, 2018 | 3.553B |
December 31, 2017 | 5.097B |
September 30, 2017 | 6.687B |
June 30, 2017 | 6.009B |
March 31, 2017 | 4.998B |
December 31, 2016 | 4.636B |
September 30, 2016 | 6.469B |
June 30, 2016 | 5.64B |
March 31, 2016 | 4.643B |
December 31, 2015 | 3.945B |
September 30, 2015 | 4.863B |
June 30, 2015 | 5.504B |
March 31, 2015 | 1.377B |
December 31, 2014 | 1.742B |
September 30, 2014 | 4.645B |
June 30, 2014 | 5.218B |
March 31, 2014 | 4.697B |
December 31, 2013 | 4.492B |
September 30, 2013 | 3.577B |
June 30, 2013 | 3.558B |
March 31, 2013 | 2.957B |
December 31, 2012 | 3.363B |
September 30, 2012 | 15.67B |
June 30, 2012 | 11.51B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-8.172B
Minimum
Dec 2019
17.25B
Maximum
Dec 2022
10.81B
Average
13.18B
Median
Shareholders Equity (Quarterly) Benchmarks
Amgen Inc | 7.527B |
Johnson & Johnson | 70.16B |
Eli Lilly and Co | 14.24B |
Merck & Co Inc | 44.50B |
Pfizer Inc | 92.29B |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 143.42B |
Total Liabilities (Quarterly) | 137.35B |
Debt to Equity Ratio | 11.78 |
Current Ratio | 0.6452 |
Net Debt Paydown Yield | -0.58% |